Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Erben

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Onkologie|November 14, 2012
Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesionsPhilipp Erben, Daniel Nowak, Christian Sauer, et al.
The Journal of Urology|March 18, 2014
Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vesselsJulia Heinzelbecker, Matthias Gross-Weege, Christel Weiss, et al.
Blood|November 9, 2006
Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activationYing Wang, Dali Cai, Cornelia Brendel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemiaAndreas Burchert, Martin C Müller, Philippe Kostrewa, et al.
Annals of Hematology|March 26, 2013
Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II studyKirsten Merx, Alice Fabarius, Philipp Erben, et al.
International Journal of Molecular Sciences|November 13, 2021
Properties of Two Broad Host Range Phages of <i>Yersinia enterocolitica</i> Isolated from Wild AnimalsJens A Hammerl, Andrea Barac, Philipp Erben, et al.
Anticancer Research|November 1, 2016
Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder CancerMaximilian Christian Kriegmair, Matthias Balk, Ralph Wirtz, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Diagnostics (Basel, Switzerland)|March 11, 2023
An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seqFrank Waldbillig, Felix Bormann, Manuel Neuberger, et al.
Experimental & Molecular Medicine|December 31, 2024
Loss of YTHDC1 m<sup>6</sup>A reading function promotes invasiveness in urothelial carcinoma of the bladderJinyun Xu, Jonas Koch, Claudia Schmidt, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Onkologie|November 14, 2012
Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesionsPhilipp Erben, Daniel Nowak, Christian Sauer, et al.
The Journal of Urology|March 18, 2014
Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vesselsJulia Heinzelbecker, Matthias Gross-Weege, Christel Weiss, et al.
Blood|November 9, 2006
Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activationYing Wang, Dali Cai, Cornelia Brendel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemiaAndreas Burchert, Martin C Müller, Philippe Kostrewa, et al.
Annals of Hematology|March 26, 2013
Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II studyKirsten Merx, Alice Fabarius, Philipp Erben, et al.
International Journal of Molecular Sciences|November 13, 2021
Properties of Two Broad Host Range Phages of <i>Yersinia enterocolitica</i> Isolated from Wild AnimalsJens A Hammerl, Andrea Barac, Philipp Erben, et al.
Anticancer Research|November 1, 2016
Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder CancerMaximilian Christian Kriegmair, Matthias Balk, Ralph Wirtz, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Diagnostics (Basel, Switzerland)|March 11, 2023
An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seqFrank Waldbillig, Felix Bormann, Manuel Neuberger, et al.
Experimental & Molecular Medicine|December 31, 2024
Loss of YTHDC1 m<sup>6</sup>A reading function promotes invasiveness in urothelial carcinoma of the bladderJinyun Xu, Jonas Koch, Claudia Schmidt, et al.
Pageof 13